📰 Sartorius expands its collaboration with NVIDIA to develop new therapies using AI-powered computing platforms and software. 🧪🖥️ The collaboration aims to simplify and accelerate biopharma drug discovery and manufacturing. 💊💡 Sartorius will integrate NVIDIA’s technology into its instruments and use AI models to replace animal models in drug development and precision medicine. 🦠🔬 The expanded collaboration includes the adoption of NVIDIA’s Clara suite and the creation of predictive AI models and simulations.
📢 Sartorius Revolutionizes Drug Discovery with NVIDIA Collaboration
Introduction:
Sartorius is expanding its collaboration with NVIDIA to enhance the development of new therapies by integrating Sartorius’ expertise in life sciences and bioprocessing with NVIDIA’s AI-powered computing platforms and software. The goal of this collaboration is to simplify and accelerate the process of drug discovery and manufacturing in the biopharma industry.
Main points:
- Sartorius has been working with NVIDIA since 2020, integrating NVIDIA technology into its instruments for AI-assisted assays in the lab.
- The collaboration focuses on developing predictive AI models of stem cell-derived organoids to replace animal models in drug discovery and precision medicine.
- NVIDIA Clara suite of AI-powered computing platforms, software, and services will be adopted and commercialized in the Sartorius ecosystem.
- The collaboration will include creating foundational models based on Sartorius’ data sets and providing new predictive AI models, tools, and simulations for various applications.
- The collaboration will explore advanced technologies such as computer-based design and simulation of complex 3D-bioprinted spheroids and organoids, as well as synthetic biological pathways and organisms.
Conclusion:
By expanding its collaboration with NVIDIA, Sartorius aims to leverage AI-powered computing platforms and software to drive innovation in drug discovery and biomanufacturing. The integration of AI with life sciences expertise has the potential to simplify and accelerate the development of new therapies, ultimately benefiting patients.
